Akshay Sood to Neoplasm Staging
This is a "connection" page, showing publications Akshay Sood has written about Neoplasm Staging.
Connection Strength
0.780
-
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA. Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma. Clin Genitourin Cancer. 2025 Dec; 23(6):102422.
Score: 0.054
-
Bertini A, Tylecki A, Stephens A, Finocchiaro A, Vigan? S, Cusmano N, Dinesh A, Guivatchian E, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. Socioeconomic Disparities in Prostate Cancer Presentation: The Impact of ADI on Prostate Cancer Stage at Diagnosis. Clin Genitourin Cancer. 2025 Dec; 23(6):102418.
Score: 0.054
-
Finocchiaro A, Tylecki A, Vigan? S, Bertini A, Ficarra V, Di Trapani E, Salonia A, Briganti A, Montorsi F, Lughezzani G, Buffi N, Sood A, Rogers C, Abdollah F. Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis. JNCI Cancer Spectr. 2025 Jul 01; 9(4).
Score: 0.054
-
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA. Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma. Urol Oncol. 2025 Oct; 43(10):597.e5-597.e14.
Score: 0.054
-
Rakic I, Rakic N, Stephens A, Corsi N, Davis M, Tinsley S, Butaney M, Arora S, Sood A, Autorino R, Rogers C, Abdollah F. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis. Urol Oncol. 2023 10; 41(10):435.e1-435.e9.
Score: 0.047
-
Andrews JR, Sood A, Chapin BF. Point-Counterpoint: Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Detecting Clinically Node Positive Prostate Cancer. J Urol. 2023 08; 210(2):242-243.
Score: 0.046
-
Jamil M, Hanna R, Sood A, Corsi N, Modonutti D, Keeley J, Etta P, Novara G, Patel A, Rogers C, Abdollah F. Renal Tumor Size and Presence of Synchronous Lung Metastasis at Time of Diagnosis: Implications for Chest Imaging. Urology. 2021 12; 158:110-116.
Score: 0.041
-
Jamil M, Rakic N, Sood A, Keeley J, Modonutti D, Novara G, Jeong W, Menon M, Rogers CG, Abdollah F. Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis. Clin Genitourin Cancer. 2021 10; 19(5):e319-e325.
Score: 0.040
-
Rakic N, Sood A, Dalela D, Arora S, Malovana U, Keeley J, Rogers C, Peabody J, Menon M, Abdollah F. A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients. Clin Genitourin Cancer. 2020 12; 18(6):489-499.e6.
Score: 0.038
-
Bronkema C, Arora S, Sood A, Dalela D, Keeley J, Borchert A, Baumgarten L, Rogers CG, Peabody JO, Menon M, Abdollah F. Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis. J Urol. 2020 08; 204(2):260-266.
Score: 0.037
-
Abdollah F, Dalela D, Sood A, Keeley J, Alanee S, Briganti A, Montorsi F, Peabody JO, Menon M. Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection. Eur Urol. 2018 09; 74(3):253-256.
Score: 0.033
-
Vetterlein MW, L?ppenberg B, Karabon P, Dalela D, Jindal T, Sood A, Chun FK, Trinh QD, Menon M, Abdollah F. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017 Sep 01; 123(17):3241-3252.
Score: 0.031
-
Vetterlein MW, Karabon P, Dalela D, Jindal T, Sood A, Seisen T, Trinh QD, Menon M, Abdollah F. Impact of Baseline Characteristics on the Survival Benefit of High-Intensity Local Treatment in Metastatic Urothelial Carcinoma of the Bladder. Eur Urol Focus. 2018 07; 4(4):568-571.
Score: 0.030
-
Dalela D, Karabon P, Sammon J, Sood A, L?ppenberg B, Trinh QD, Menon M, Abdollah F. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer. Eur Urol. 2017 04; 71(4):511-514.
Score: 0.029
-
Moschini M, Fossati N, Sood A, Lee JK, Sammon J, Sun M, Pucheril D, Dalela D, Montorsi F, Karnes RJ, Briganti A, Trinh QD, Menon M, Abdollah F. Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study. Eur Urol Focus. 2018 01; 4(1):68-74.
Score: 0.029
-
L?ppenberg B, Dalela D, Karabon P, Sood A, Sammon JD, Meyer CP, Sun M, Noldus J, Peabody JO, Trinh QD, Menon M, Abdollah F. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis. Eur Urol. 2017 07; 72(1):14-19.
Score: 0.029
-
Abdollah F, Dalela D, Sood A, Sammon J, Jeong W, Beyer B, Fossati N, Rogers CG, Diaz-Insua M, Peabody J, Haese A, Montorsi F, Graefen M, Briganti A, Menon M. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis. World J Urol. 2016 Oct; 34(10):1357-66.
Score: 0.028
-
Fossati N, Nguyen DP, Trinh QD, Sammon J, Sood A, Larcher A, Guazzoni G, Montorsi F, Briganti A, Menon M, Abdollah F. The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer. J Natl Compr Canc Netw. 2015 Nov; 13(11):1351-8.
Score: 0.028
-
Abdollah F, Moschini M, Sood A, Sammon J, Dalela D, Hsu L, Beyer B, Haese A, Graefen M, Gandaglia G, Montorsi F, Briganti A, Menon M. When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database. J Endourol. 2016 Feb; 30(2):201-7.
Score: 0.027
-
Abdollah F, Sood A, Sammon JD, Hsu L, Beyer B, Moschini M, Gandaglia G, Rogers CG, Haese A, Montorsi F, Graefen M, Briganti A, Menon M. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients. Eur Urol. 2015 Sep; 68(3):497-505.
Score: 0.027
-
Fossati N, Trinh QD, Sammon J, Sood A, Larcher A, Sun M, Karakiewicz P, Guazzoni G, Montorsi F, Briganti A, Menon M, Abdollah F. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study. Eur Urol. 2015 Jan; 67(1):3-6.
Score: 0.025